VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,305 | -50.8% | 116,468 | +28.8% | 0.00% | -100.0% |
| Q2 2023 | $2,218,493 | +35.9% | 90,440 | +29.0% | 0.00% | – |
| Q1 2023 | $1,631,855 | +922.9% | 70,127 | +1012.6% | 0.00% | – |
| Q4 2022 | $159,530 | -27.2% | 6,303 | -44.5% | 0.00% | – |
| Q3 2022 | $219,000 | -32.6% | 11,363 | -10.9% | 0.00% | – |
| Q2 2022 | $325,000 | -70.1% | 12,748 | -69.8% | 0.00% | – |
| Q1 2022 | $1,086,000 | -56.9% | 42,219 | -29.8% | 0.00% | -100.0% |
| Q4 2021 | $2,519,000 | -4.4% | 60,182 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $2,635,000 | +212.9% | 60,559 | +240.3% | 0.00% | – |
| Q2 2021 | $842,000 | -27.0% | 17,798 | -20.9% | 0.00% | – |
| Q1 2021 | $1,154,000 | -57.0% | 22,509 | -77.5% | 0.00% | -100.0% |
| Q4 2020 | $2,681,000 | +89.1% | 100,111 | +142.2% | 0.00% | – |
| Q3 2020 | $1,418,000 | -48.8% | 41,340 | -38.9% | 0.00% | -100.0% |
| Q2 2020 | $2,771,000 | +575.9% | 67,634 | +465.5% | 0.00% | – |
| Q1 2020 | $410,000 | +5757.1% | 11,960 | +1937.5% | 0.00% | – |
| Q4 2019 | $7,000 | – | 587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |